Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4311)
All Articles published online
|
Jul 10, 2012 (publication date) through Jun 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Supuran CT. Inhibition of carbonic anhydrase IX as a novel anticancer mechanism. World J Clin Oncol 2012; 3(7): 98-103 [PMID: 22787577 DOI: 10.5306/wjco.v3.i7.98] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v3/i7/98.htm |
| Number | Citing Articles |
| 1 |
Cem Yamali, Halise Inci Gul, Abdulilah Ece, Silvia Bua, Andrea Angeli, Hiroshi Sakagami, Ertan Sahin, Claudiu T. Supuran. Synthesis, biological evaluation and in silico modelling studies of 1,3,5-trisubstituted pyrazoles carrying benzenesulfonamide as potential anticancer agents and selective cancer-associated hCA IX isoenzyme inhibitors. Bioorganic Chemistry 2019; 92: 103222 doi: 10.1016/j.bioorg.2019.103222
|
| 2 |
Halise Inci Gul, Ebru Mete, Sakip Emre Eren, Hiroshi Sakagami, Cem Yamali, Claudiu T. Supuran. Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides. Journal of Enzyme Inhibition and Medicinal Chemistry 2017; 32(1): 169 doi: 10.1080/14756366.2016.1243536
|
| 3 |
Vasileios Askoxylakis, Volker Ehemann, Shoaib Rana, Susanne Krämer, Nuh N. Rahbari, Jürgen Debus, Uwe Haberkorn. Binding of the Phage Display Derived Peptide CaIX-P1 on Human Colorectal Carcinoma Cells Correlates with the Expression of Carbonic Anhydrase IX. International Journal of Molecular Sciences 2012; 13(10): 13030 doi: 10.3390/ijms131013030
|
| 4 |
Ismail Koyuncu, Ebru Temiz, Eray Metin Güler, Mustafa Durgun, Ozgür Yuksekdag, Simone Giovannuzzi, Claudiu T. Supuran. Effective Anticancer Potential of a New Sulfonamide as a Carbonic Anhydrase IX Inhibitor Against Aggressive Tumors. ChemMedChem 2024; 19(9) doi: 10.1002/cmdc.202300680
|
| 5 |
Kunal N. More, Jun Young Lee, Dong-Yeon Kim, Nam-Chul Cho, Ayoung Pyo, Misun Yun, Hyeon Sik Kim, Hangun Kim, Kwangseok Ko, Jeong-Hoon Park, Dong-Jo Chang. Acetazolamide-based [ 18 F]-PET tracer: In vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors. Bioorganic & Medicinal Chemistry Letters 2018; 28(5): 915 doi: 10.1016/j.bmcl.2018.01.060
|
| 6 |
Christopher Boone, Andrew Habibzadegan, Sonika Gill, Robert McKenna. Carbonic Anhydrases and Their Biotechnological Applications. Biomolecules 2013; 3(3): 553 doi: 10.3390/biom3030553
|
| 7 |
Virginija Dudutienė, Jurgita Matulienė, Alexey Smirnov, David D. Timm, Asta Zubrienė, Lina Baranauskienė, Vaida Morku̅naitė, Joana Smirnovienė, Vilma Michailovienė, Vaida Juozapaitienė, Aurelija Mickevičiu̅tė, Justina Kazokaitė, Sandra Bakšytė, Aistė Kasiliauskaitė, Jelena Jachno, Jurgita Revuckienė, Miglė Kišonaitė, Vilma Pilipuitytė, Eglė Ivanauskaitė, Goda Milinavičiu̅tė, Vytautas Smirnovas, Vilma Petrikaitė, Visvaldas Kairys, Vytautas Petrauskas, Povilas Norvaišas, Darius Lingė, Paulius Gibieža, Edita Čapkauskaitė, Audrius Zakšauskas, Egidijus Kazlauskas, Elena Manakova, Saulius Gražulis, John E. Ladbury, Daumantas Matulis. Discovery and Characterization of Novel Selective Inhibitors of Carbonic Anhydrase IX. Journal of Medicinal Chemistry 2014; 57(22): 9435 doi: 10.1021/jm501003k
|
| 8 |
Jarosław Sławiński, Krzysztof Szafrański, Daniela Vullo, Claudiu T. Supuran. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII. European Journal of Medicinal Chemistry 2013; 69: 701 doi: 10.1016/j.ejmech.2013.09.027
|
| 9 |
J.L. Bryant, S.L. Meredith, K.J. Williams, A. White. Targeting hypoxia in the treatment of small cell lung cancer. Lung Cancer 2014; 86(2): 126 doi: 10.1016/j.lungcan.2014.08.003
|
| 10 |
Samar A. El-Kalyoubi, Ehab S. Taher, Tarek S. Ibrahim, Mohammed Farrag El-Behairy, Amany M. M. Al-Mahmoudy. Uracil as a Zn-Binding Bioisostere of the Allergic Benzenesulfonamide in the Design of Quinoline–Uracil Hybrids as Anticancer Carbonic Anhydrase Inhibitors. Pharmaceuticals 2022; 15(5): 494 doi: 10.3390/ph15050494
|
| 11 |
Nagwa M. Abdel Gawad, Noha H. Amin, Mohammed T. Elsaadi, Fatma M.M. Mohamed, Andrea Angeli, Viviana De Luca, Clemente Capasso, Claudiu T. Supuran. Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines. Bioorganic & Medicinal Chemistry 2016; 24(13): 3043 doi: 10.1016/j.bmc.2016.05.016
|
| 12 |
Fangli Chen, Emilia Licarete, Xue Wu, Daniela Petrusca, Callista Maguire, Max Jacobsen, Austyn Colter, George E. Sandusky, Magdalena Czader, Maegan L. Capitano, James P. Ropa, H. Scott Boswell, Fabrizio Carta, Claudiu T. Supuran, Brian Parkin, Melissa L. Fishel, Heiko Konig. Pharmacological inhibition of Carbonic Anhydrase IX and XII to enhance targeting of acute myeloid leukaemia cells under hypoxic conditions. Journal of Cellular and Molecular Medicine 2021; 25(24): 11039 doi: 10.1111/jcmm.17027
|
| 13 |
Paul C. McDonald, Shoukat Dedhar. Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications. Subcellular Biochemistry 2014; 75: 255 doi: 10.1007/978-94-007-7359-2_13
|
| 14 |
Mohamed Fares, Sahar Mahmoud Abou-Seri, Hatem A. Abdel-Aziz, Safinaz E.-S. Abbas, Mohieldin Magdy Youssef, Radwa Ahmed Eladwy. Synthesis and antitumor activity of pyrido [2,3-d]pyrimidine and pyrido[2,3-d] [1,2,4]triazolo[4,3-a]pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest. European Journal of Medicinal Chemistry 2014; 83: 155 doi: 10.1016/j.ejmech.2014.06.027
|
| 15 |
Elisabetta Iessi, Mariantonia Logozzi, Davide Mizzoni, Rossella Di Raimo, Claudiu Supuran, Stefano Fais. Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy. Metabolites 2017; 8(1): 2 doi: 10.3390/metabo8010002
|
| 16 |
Jennifer Schmidt, Elsie Oppermann, Roman A. Blaheta, Teresa Schreckenbach, Ilaria Lunger, Michael A. Rieger, Wolf Otto Bechstein, Katharina Holzer, Patrizia Malkomes. Carbonic-anhydrase IX expression is increased in thyroid cancer tissue and represents a potential therapeutic target to eradicate thyroid tumor-initiating cells. Molecular and Cellular Endocrinology 2021; 535: 111382 doi: 10.1016/j.mce.2021.111382
|
| 17 |
Rita Meleddu, Simona Distinto, Filippo Cottiglia, Rossella Angius, Marco Gaspari, Domenico Taverna, Claudia Melis, Andrea Angeli, Giulia Bianco, Serenella Deplano, Benedetta Fois, Sonia Del Prete, Clemente Capasso, Stefano Alcaro, Francesco Ortuso, Matilde Yanez, Claudiu T. Supuran, Elias Maccioni. Tuning the Dual Inhibition of Carbonic Anhydrase and Cyclooxygenase by Dihydrothiazole Benzensulfonamides. ACS Medicinal Chemistry Letters 2018; 9(10): 1045 doi: 10.1021/acsmedchemlett.8b00352
|
| 18 |
Mahmoud S. Bashandy, Mansour S. Alsaid, Reem K. Arafa, Mostafa M. Ghorab. Design, synthesis and molecular docking of novelN,N-dimethylbenzenesulfonamide derivatives as potential antiproliferative agents. Journal of Enzyme Inhibition and Medicinal Chemistry 2014; 29(5): 619 doi: 10.3109/14756366.2013.833197
|
| 19 |
Murtuza Hadianawala, Bhaskar Datta. Design and development of sulfonylurea derivatives as zinc metalloenzyme modulators. RSC Advances 2016; 6(11): 8923 doi: 10.1039/C5RA27341B
|
| 20 |
Joseph Lau, Zhibo Liu, Kuo-Shyan Lin, Jinhe Pan, Zhengxing Zhang, Daniela Vullo, Claudiu T. Supuran, David M. Perrin, François Bénard. Trimeric Radiofluorinated Sulfonamide Derivatives to Achieve In Vivo Selectivity for Carbonic Anhydrase IX–Targeted PET Imaging. Journal of Nuclear Medicine 2015; 56(9): 1434 doi: 10.2967/jnumed.114.153288
|
| 21 |
Samuele Cazzamalli, Alberto Dal Corso, Dario Neri. Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma. Journal of Controlled Release 2017; 246: 39 doi: 10.1016/j.jconrel.2016.11.023
|
| 22 |
Aaron R. Huber, Dongfeng Tan, Jun Sun, David Dean, Tongtong Wu, Zhongren Zhou. High expression of carbonic anhydrase IX is significantly associated with glandular lesions in gastroesophageal junction and with tumorigenesis markers BMI1, MCM4 and MCM7. BMC Gastroenterology 2015; 15(1) doi: 10.1186/s12876-015-0310-6
|
| 23 |
Ismail Koyuncu, Ebru Temiz, Mustafa Durgun, Abdurrahim Kocyigit, Ozgur Yuksekdag, Claudiu T. Supuran. Intracellular pH-mediated induction of apoptosis in HeLa cells by a sulfonamide carbonic anhydrase inhibitor. International Journal of Biological Macromolecules 2022; 201: 37 doi: 10.1016/j.ijbiomac.2021.12.190
|
| 24 |
Werner E. G. Müller, Heinz C. Schröder, Emad Tolba, Bärbel Diehl‐Seifert, Xiaohong Wang. Mineralization of bone‐related SaOS‐2 cells under physiological hypoxic conditions. The FEBS Journal 2016; 283(1): 74 doi: 10.1111/febs.13552
|
| 25 |
Ahmed M. Alafeefy, Hatem A. Abdel-Aziz, F. Carta, Claudiu T. Supuran, Shilendra K. Pathak, Onkar Prasad, Leena Sinha. Exploring QSARs of some benzenesulfonamides incorporating cyanoacrylamide moieties as a carbonic anhydrase inhibitors (specifically against tumor-associated isoforms IX and XII). Journal of Enzyme Inhibition and Medicinal Chemistry 2015; 30(4): 519 doi: 10.3109/14756366.2014.948435
|
| 26 |
Roben G. Gieling, Catriona A. Parker, Lisa A. De Costa, Naomi Robertson, Adrian L. Harris, Ian J. Stratford, Kaye J. Williams. Inhibition of carbonic anhydrase activity modifies the toxicity of doxorubicin and melphalan in tumour cellsin vitro. Journal of Enzyme Inhibition and Medicinal Chemistry 2013; 28(2): 360 doi: 10.3109/14756366.2012.736979
|
| 27 |
Pınar Eraslan‐Elma, Atilla Akdemir, Emanuela Berrino, Murat Bozdağ, Claudiu T. Supuran, Nilgün Karalı. New 1H‐indole‐2,3‐dione 3‐thiosemicarbazones with 3‐sulfamoylphenyl moiety as selective carbonic anhydrase inhibitors. Archiv der Pharmazie 2022; 355(8) doi: 10.1002/ardp.202200023
|
| 28 |
Ayse Er. Various Carbonic Anhydrases in Physiopathological Events, Carbonic
Anhydrase Inhibitors, and Hybrid Compounds. Letters in Drug Design & Discovery 2023; 20(10): 1427 doi: 10.2174/1570180819666220530151210
|
| 29 |
Akilah B. Murray, Marta Quadri, Haoxi Li, Robert McKenna, Nicole A. Horenstein. Synthesis of saccharin-glycoconjugates targeting carbonic anhydrase using a one-pot cyclization/deprotection strategy. Carbohydrate Research 2019; 476: 65 doi: 10.1016/j.carres.2019.03.001
|
| 30 |
Rita Meleddu, Serenella Deplano, Elias Maccioni, Francesco Ortuso, Filippo Cottiglia, Daniela Secci, Alessia Onali, Erica Sanna, Andrea Angeli, Rossella Angius, Stefano Alcaro, Claudiu T. Supuran, Simona Distinto. Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry 2021; 36(1): 685 doi: 10.1080/14756366.2021.1887171
|
| 31 |
Geoff S Higgins, Adrian L Harris. Hypoxia and Cancer. Cancer Drug Discovery and Development 2014; : 343 doi: 10.1007/978-1-4614-9167-5_15
|
| 32 |
Erik O. Pettersen, Peter Ebbesen, Roben G. Gieling, Kaye J. Williams, Ludwig Dubois, Philippe Lambin, Carol Ward, James Meehan, Ian H. Kunkler, Simon P. Langdon, Anne H. Ree, Kjersti Flatmark, Heidi Lyng, Maria J. Calzada, Luis del Peso, Manuel O. Landazuri, Agnes Görlach, Hubert Flamm, Jochen Kieninger, Gerald Urban, Andreas Weltin, Dean C. Singleton, Syed Haider, Francesca M. Buffa, Adrian L. Harris, Andrea Scozzafava, Claudiu T. Supuran, Isabella Moser, Gerhard Jobst, Morten Busk, Kasper Toustrup, Jens Overgaard, Jan Alsner, Jacques Pouyssegur, Johanna Chiche, Nathalie Mazure, Ibtissam Marchiq, Scott Parks, Afshan Ahmed, Margaret Ashcroft, Silvia Pastorekova, Yihai Cao, Kasper M. Rouschop, Brad G. Wouters, Marianne Koritzinsky, Hilda Mujcic, Dan Cojocari. Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium. Journal of Enzyme Inhibition and Medicinal Chemistry 2015; 30(5): 689 doi: 10.3109/14756366.2014.966704
|
| 33 |
Andrea Angeli, Elena Trallori, Fabrizio Carta, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Claudiu T. Supuran. Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines. ACS Medicinal Chemistry Letters 2018; 9(9): 947 doi: 10.1021/acsmedchemlett.8b00362
|
| 34 |
Z‐W Lee, X‐Y Teo, E Y‐W Tay, C‐H Tan, T Hagen, P K Moore, L‐W Deng. Utilizing hydrogen sulfide as a novel anti‐cancer agent by targeting cancer glycolysis and pH imbalance. British Journal of Pharmacology 2014; 171(18): 4322 doi: 10.1111/bph.12773
|
| 35 |
Akın Akıncıoğlu, Ebutalib Kocaman, Hülya Akıncıoğlu, Ramin Ekhteiari Salmas, Serdar Durdagi, İlhami Gülçin, Claudiu T. Supuran, Süleyman Göksu. The synthesis of novel sulfamides derived from β-benzylphenethylamines as acetylcholinesterase, butyrylcholinesterase and carbonic anhydrase enzymes inhibitors. Bioorganic Chemistry 2017; 74: 238 doi: 10.1016/j.bioorg.2017.08.012
|
| 36 |
Paul C. McDonald, Shawn C. Chafe, Shoukat Dedhar. Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction. Frontiers in Cell and Developmental Biology 2016; 4 doi: 10.3389/fcell.2016.00027
|
| 37 |
Julieta Afonso, Lúcio L. Santos, Vera Miranda‐Gonçalves, António Morais, Teresina Amaro, Adhemar Longatto‐Filho, Fátima Baltazar. CD147 and MCT1‐potential partners in bladder cancer aggressiveness and cisplatin resistance. Molecular Carcinogenesis 2015; 54(11): 1451 doi: 10.1002/mc.22222
|
| 38 |
Krzysztof Szafrański, Jarosław Sławiński. Synthesis of Novel 1-(4-Substituted pyridine-3-sulfonyl)-3-phenylureas with Potential Anticancer Activity. Molecules 2015; 20(7): 12029 doi: 10.3390/molecules200712029
|
| 39 |
Claudia Melis, Simona Distinto, Giulia Bianco, Rita Meleddu, Filippo Cottiglia, Benedetta Fois, Domenico Taverna, Rossella Angius, Stefano Alcaro, Francesco Ortuso, Marco Gaspari, Andrea Angeli, Sonia Del Prete, Clemente Capasso, Claudiu T. Supuran, Elias Maccioni. Targeting Tumor Associated Carbonic Anhydrases IX and XII: Highly Isozyme Selective Coumarin and Psoralen Inhibitors. ACS Medicinal Chemistry Letters 2018; 9(7): 725 doi: 10.1021/acsmedchemlett.8b00170
|
| 40 |
Bettina von Neubeck, Gabor Gondi, Chiara Riganti, Chenchen Pan, Arnaldo Parra Damas, Hagen Scherb, Ali Ertürk, Reinhard Zeidler. An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo. International Journal of Cancer 2018; 143(8): 2065 doi: 10.1002/ijc.31607
|
| 41 |
Suleyman Akocak, M. Raqibul Alam, Ahmed M. Shabana, Rajesh Kishore Kumar Sanku, Daniela Vullo, Harry Thompson, Erik R. Swenson, Claudiu T. Supuran, Marc A. Ilies. PEGylated Bis-Sulfonamide Carbonic Anhydrase Inhibitors Can Efficiently Control the Growth of Several Carbonic Anhydrase IX-Expressing Carcinomas. Journal of Medicinal Chemistry 2016; 59(10): 5077 doi: 10.1021/acs.jmedchem.6b00492
|
| 42 |
Afaf El-Malah, Ehab S. Taher, Andrea Angeli, Samar S. Elbaramawi, Zeinab Mahmoud, Nour Moustafa, Claudiu T. Supuran, Tarek S. Ibrahim. Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX/XII inhibitors: A new regioisomerism tactic. Bioorganic Chemistry 2023; 131: 106309 doi: 10.1016/j.bioorg.2022.106309
|
| 43 |
Claudia Melis, Rita Meleddu, Andrea Angeli, Simona Distinto, Giulia Bianco, Clemente Capasso, Filippo Cottiglia, Rossella Angius, Claudiu T. Supuran, Elias Maccioni. Isatin: a privileged scaffold for the design of carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2017; 32(1): 68 doi: 10.1080/14756366.2016.1235042
|
| 44 |
Alexey Smirnov, Elena Manakova, Saulius Gražulis, Robert McKenna, Daumantas Matulis. Carbonic Anhydrase as Drug Target. 2019; : 179 doi: 10.1007/978-3-030-12780-0_13
|
| 45 |
Akilah B. Murray, Carrie L. Lomelino, Claudiu T. Supuran, Robert McKenna. “Seriously Sweet”: Acesulfame K Exhibits Selective Inhibition Using Alternative Binding Modes in Carbonic Anhydrase Isoforms. Journal of Medicinal Chemistry 2018; 61(3): 1176 doi: 10.1021/acs.jmedchem.7b01470
|
| 46 |
Ismail Koyuncu, Ataman Gonel, Abdurrahim Kocyigit, Ebru Temiz, Mustafa Durgun, Claudiu T. Supuran. Selective inhibition of carbonic anhydrase-IX by sulphonamide derivatives induces pH and reactive oxygen species-mediated apoptosis in cervical cancer HeLa cells. Journal of Enzyme Inhibition and Medicinal Chemistry 2018; 33(1): 1137 doi: 10.1080/14756366.2018.1481403
|
| 47 |
Rita Meleddu, Simona Distinto, Filippo Cottiglia, Rossella Angius, Pierluigi Caboni, Andrea Angeli, Claudia Melis, Serenella Deplano, Stefano Alcaro, Francesco Ortuso, Claudiu T. Supuran, Elias Maccioni. New Dihydrothiazole Benzensulfonamides: Looking for Selectivity toward Carbonic Anhydrase Isoforms I, II, IX, and XII. ACS Medicinal Chemistry Letters 2020; 11(5): 852 doi: 10.1021/acsmedchemlett.9b00644
|
| 48 |
Peng-Cheng Lv, Karson S. Putt, Philip S. Low. Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers. Bioconjugate Chemistry 2016; 27(7): 1762 doi: 10.1021/acs.bioconjchem.6b00271
|
| 49 |
Mostafa Ghorab, Mansour Alsaid, Mohammed Al-Dosari, Marwa El-Gazzar, Ahmed Arbab. In-Vitro Anticancer Evaluation of Some Novel Thioureido-Benzensulfonamide Derivatives. Molecules 2016; 21(4): 409 doi: 10.3390/molecules21040409
|
| 50 |
Ruirong Ye, Caiping Tan, Bichun Chen, Rongtao Li, Zongwan Mao. Zinc-Containing Metalloenzymes: Inhibition by Metal-Based Anticancer Agents. Frontiers in Chemistry 2020; 8 doi: 10.3389/fchem.2020.00402
|
| 51 |
Peter Mikuš, Dominika Krajčiová, Mária Mikulová, Branislav Horváth, Daniel Pecher, Vladimír Garaj, Silvia Bua, Andrea Angeli, Claudiu T. Supuran. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX. Bioorganic Chemistry 2018; 81: 241 doi: 10.1016/j.bioorg.2018.08.005
|
| 52 |
Avik Som, Ramesh Raliya, Limei Tian, Walter Akers, Joseph E. Ippolito, Srikanth Singamaneni, Pratim Biswas, Samuel Achilefu. Monodispersed calcium carbonate nanoparticles modulate local pH and inhibit tumor growth in vivo. Nanoscale 2016; 8(25): 12639 doi: 10.1039/C5NR06162H
|
| 53 |
Simona Distinto, Rita Meleddu, Francesco Ortuso, Filippo Cottiglia, Serenella Deplano, Lisa Sequeira, Claudia Melis, Benedetta Fois, Andrea Angeli, Clemente Capasso, Rossella Angius, Stefano Alcaro, Claudiu T. Supuran, Elias Maccioni. Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases. Journal of Enzyme Inhibition and Medicinal Chemistry 2019; 34(1): 1526 doi: 10.1080/14756366.2019.1654470
|
| 54 |
Christopher D. Boone, Melissa Pinard, Rob McKenna, David Silverman. Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications. Subcellular Biochemistry 2014; 75: 31 doi: 10.1007/978-94-007-7359-2_3
|
| 55 |
Beata Żołnowska, Jarosław Sławiński, Krzysztof Szafrański, Andrea Angeli, Claudiu T. Supuran, Anna Kawiak, Miłosz Wieczór, Joanna Zielińska, Tomasz Bączek, Sylwia Bartoszewska. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies. European Journal of Medicinal Chemistry 2018; 143: 1931 doi: 10.1016/j.ejmech.2017.11.005
|
| 56 |
Mariusz Belka, Weronika Hewelt-Belka, Jarosław Sławiński, Tomasz Bączek, Frederique Lisacek. Mass Spectrometry Based Identification of Geometric Isomers during Metabolic Stability Study of a New Cytotoxic Sulfonamide Derivatives Supported by Quantitative Structure-Retention Relationships. PLoS ONE 2014; 9(6): e98096 doi: 10.1371/journal.pone.0098096
|
| 57 |
Yingmin Li, Yang Luo, Xingyang Li, Zhengjie Huang, Yi Wang. Nanoparticles breakthroughs tumor treatment limitations by regulating tumor immune microenvironment to enhance tumor immunotherapy efficacy. Smart Materials in Medicine 2021; 2: 314 doi: 10.1016/j.smaim.2021.08.004
|
| 58 |
Martin Benej, Silvia Pastorekova, Jaromir Pastorek. Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications. Subcellular Biochemistry 2014; 75: 199 doi: 10.1007/978-94-007-7359-2_11
|
| 59 |
Daniela Vullo, Mariaconcetta Durante, Francesco Saverio Di Leva, Sandro Cosconati, Emanuela Masini, Andrea Scozzafava, Ettore Novellino, Claudiu T. Supuran, Fabrizio Carta. Monothiocarbamates Strongly Inhibit Carbonic Anhydrases in Vitro and Possess Intraocular Pressure Lowering Activity in an Animal Model of Glaucoma. Journal of Medicinal Chemistry 2016; 59(12): 5857 doi: 10.1021/acs.jmedchem.6b00462
|
| 60 |
Sridhar Goud Nerella, Priti Singh, Pavitra S. Thacker, Mohammed Arifuddin, Claudiu T. Supuran. PET radiotracers and fluorescent probes for imaging human carbonic anhydrase IX and XII in hypoxic tumors. Bioorganic Chemistry 2023; 133: 106399 doi: 10.1016/j.bioorg.2023.106399
|
| 61 |
Fatima Arshad, Mohemmed Faraz Khan, Wasim Akhtar, Mohammad Mumtaz Alam, Lalit Mohan Nainwal, Sumit Kumar Kaushik, Mymoona Akhter, Suhel Parvez, Syed Misbahul Hasan, Mohammad Shaquiquzzaman. Revealing quinquennial anticancer journey of morpholine: A SAR based review. European Journal of Medicinal Chemistry 2019; 167: 324 doi: 10.1016/j.ejmech.2019.02.015
|
| 62 |
Mohammad Hasbi Ghazal, Djamila Ben Hadda, Saleh Trefi, Amir Balash, Mustapha Fawaz Chehna. New Synthetic Methods of Ureido-Substituted Benzenesulfonamides as Carbonic Anhydrase IX Inhibitors. Research Journal of Pharmacy and Technology 2023; : 3884 doi: 10.52711/0974-360X.2023.00640
|
| 63 |
Christopher D. Boone, Robert McKenna. Carbonic Anhydrases as Biocatalysts. 2015; : 291 doi: 10.1016/B978-0-444-63258-6.00016-0
|
| 64 |
Azizah M. Malebari, Tarek S. Ibrahim, Ibrahim M. Salem, Ismail Salama, Ahdab N. Khayyat, Samia M. Mostafa, Osama I. El-Sabbagh, Khaled M. Darwish. The Anticancer Activity for the Bumetanide-Based Analogs via Targeting the Tumor-Associated Membrane-Bound Human Carbonic Anhydrase-IX Enzyme. Pharmaceuticals 2020; 13(9): 252 doi: 10.3390/ph13090252
|
| 65 |
Mostafa M. Ghorab, Fatma A. Ragab, Helmy I. Heiba, Aiten M. Soliman. Design and synthesis of some novel 4-Chloro- N -(4-(1-(2-(2-cyanoacetyl)hydrazono)ethyl)phenyl) benzenesulfonamide derivatives as anticancer and radiosensitizing agents. European Journal of Medicinal Chemistry 2016; 117: 8 doi: 10.1016/j.ejmech.2016.04.009
|
| 66 |
Tarik Corbo, Abdurahim Kalajdzic, Dzelila Delic, Sumaia Suleiman, Naris Pojskic. In silico prediction suggests inhibitory effect of halogenated boroxine on human catalase and carbonic anhydrase. Journal of Genetic Engineering and Biotechnology 2022; 20(1): 153 doi: 10.1186/s43141-022-00437-x
|
| 67 |
Afrah E. Mohammed, Fuad Ameen, Kawther Aabed, Rasha Saad Suliman, Sahar Saleh Alghamdi, Fatmah Ahmed Safhi, Dalal Sulaiman Alshaya, Hayat Ali Alafari, Areej S. Jalal, Areej A. Alosaimi, Salha Mesfer Alshamrani, Ishrat Rahman. In-silico predicting as a tool to develop plant-based biomedicines and nanoparticles: Lycium shawii metabolites. Biomedicine & Pharmacotherapy 2022; 150: 113008 doi: 10.1016/j.biopha.2022.113008
|
| 68 |
Wenyun Ye, Cheng Zhang, Na Xu, Yan Sun, Lei Ma, Bo Shen, Dan Zhou, Changliang Zhu. Carbonic anhydrase II confers resistance to deltamethrin in Culex pipiens pallens. Archives of Insect Biochemistry and Physiology 2017; 96(4) doi: 10.1002/arch.21428
|
| 69 |
Adelina Luong-Player, Haiyan Liu, Hanlin L. Wang, Fan Lin. Immunohistochemical Reevaluation of Carbonic Anhydrase IX (CA IX) Expression in Tumors and Normal Tissues. American Journal of Clinical Pathology 2014; 141(2): 219 doi: 10.1309/AJCPVJDS28KNYZLD
|
| 70 |
Oana C. Kulterer, Sarah Pfaff, Wolfgang Wadsak, Nathalie Garstka, Mesut Remzi, Chrysoula Vraka, Lukas Nics, Markus Mitterhauser, Franziska Bootz, Samuele Cazzamalli, Nikolaus Krall, Dario Neri, Alexander R. Haug. A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients. Journal of Nuclear Medicine 2021; 62(3): 360 doi: 10.2967/jnumed.120.245530
|
| 71 |
Mostafa M. Ghorab, Fatma A. Ragab, Helmy I. Heiba, Aiten M. Soliman. Anticancer and radio-sensitizing evaluation of some new sulfonamide derivatives bearing pyridone, thiophene, and hydrazone moieties. Research on Chemical Intermediates 2017; 43(8): 4657 doi: 10.1007/s11164-017-2903-x
|
| 72 |
Carlos Pérez, C. Vanesa Díaz-García, Alba Agudo-López, Virginia del Solar, Silvia Cabrera, M. Teresa Agulló-Ortuño, Carmen Navarro-Ranninger, José Alemán, José A. López-Martín. Evaluation of novel trans-sulfonamide platinum complexes against tumor cell lines. European Journal of Medicinal Chemistry 2014; 76: 360 doi: 10.1016/j.ejmech.2014.02.022
|
| 73 |
Sandra F. Lam, Kevin W. Bishop, Rachel Mintz, Lei Fang, Samuel Achilefu. Calcium carbonate nanoparticles stimulate cancer cell reprogramming to suppress tumor growth and invasion in an organ-on-a-chip system. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88687-6
|
| 74 |
Navneet Chandak, Mariangela Ceruso, Claudiu T. Supuran, Pawan K. Sharma. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII. Bioorganic & Medicinal Chemistry 2016; 24(13): 2882 doi: 10.1016/j.bmc.2016.04.052
|